19-11033334-C-G

Variant summary

Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PP2

The NM_001387283.1(SMARCA4):​c.3591C>G​(p.Asn1197Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. N1197N) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 33)

Consequence

SMARCA4
NM_001387283.1 missense

Scores

3
8
8

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.51
Variant links:
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 5 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 7 uncertain in NM_001387283.1
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SMARCA4. . Gene score misZ 6.8459 (greater than the threshold 3.09). Trascript score misZ 8.7957 (greater than threshold 3.09). GenCC has associacion of gene with uterine corpus sarcoma, Coffin-Siris syndrome 1, intellectual disability, autosomal dominant 16, rhabdoid tumor predisposition syndrome 2, familial rhabdoid tumor, hereditary nonpolyposis colon cancer, Coffin-Siris syndrome.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SMARCA4NM_001387283.1 linkuse as main transcriptc.3591C>G p.Asn1197Lys missense_variant 26/36 ENST00000646693.2
SMARCA4NM_003072.5 linkuse as main transcriptc.3591C>G p.Asn1197Lys missense_variant 26/35 ENST00000344626.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SMARCA4ENST00000646693.2 linkuse as main transcriptc.3591C>G p.Asn1197Lys missense_variant 26/36 NM_001387283.1
SMARCA4ENST00000344626.10 linkuse as main transcriptc.3591C>G p.Asn1197Lys missense_variant 26/351 NM_003072.5 P4P51532-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 13, 2022The p.N1197K variant (also known as c.3591C>G), located in coding exon 25 of the SMARCA4 gene, results from a C to G substitution at nucleotide position 3591. The asparagine at codon 1197 is replaced by lysine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Missense and in-frame variants in SMARCA4 are known to cause neurodevelopmental disorders; however, such associations with rhabdoid tumor predisposition syndrome including small cell carcinoma of the ovary-hypercalcemic type (SCCOHT) are exceedingly rare (Kosho T et al. Am J Med Genet C Semin Med Genet. 2014 Sep;166C(3):262-75; Jelinic P et al. Nat Genet. 2014 May;46(5):424-6). Based on the supporting evidence, the association of this alteration with Coffin-Siris syndrome is unknown; however, the association of this alteration with rhabdoid tumor predisposition syndrome is unlikely. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.89
BayesDel_addAF
Uncertain
0.048
T
BayesDel_noAF
Benign
-0.17
CADD
Benign
1.7
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.72
D;.;T;.;.;.;.;.;.;.;D;.;.;.;.;.;T;T;.;.;.
Eigen
Benign
-1.0
Eigen_PC
Benign
-0.98
FATHMM_MKL
Benign
0.31
N
LIST_S2
Uncertain
0.94
.;D;.;.;.;.;D;.;.;.;D;.;D;D;D;D;D;D;D;D;D
M_CAP
Pathogenic
0.75
D
MetaRNN
Uncertain
0.45
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.14
D
MutationAssessor
Benign
-0.58
N;.;.;.;N;N;.;N;N;N;N;N;N;N;N;N;.;.;.;.;.
MutationTaster
Benign
0.99
D;D;D;D;D;D;D;D;D
PrimateAI
Pathogenic
0.92
D
PROVEAN
Uncertain
-3.8
D;.;.;.;.;.;.;.;.;.;D;.;D;.;D;.;.;D;.;.;.
REVEL
Uncertain
0.39
Sift
Benign
0.13
T;.;.;.;.;.;.;.;.;.;T;.;T;.;T;.;.;T;.;.;.
Sift4G
Benign
0.17
T;.;.;.;.;.;.;.;.;.;T;.;T;T;T;T;T;T;.;.;.
Polyphen
0.0010
B;.;B;.;.;.;.;.;.;.;B;.;.;.;.;.;.;B;.;.;.
Vest4
0.86
MutPred
0.52
Gain of methylation at N1197 (P = 0.0037);Gain of methylation at N1197 (P = 0.0037);Gain of methylation at N1197 (P = 0.0037);Gain of methylation at N1197 (P = 0.0037);Gain of methylation at N1197 (P = 0.0037);Gain of methylation at N1197 (P = 0.0037);Gain of methylation at N1197 (P = 0.0037);Gain of methylation at N1197 (P = 0.0037);Gain of methylation at N1197 (P = 0.0037);Gain of methylation at N1197 (P = 0.0037);Gain of methylation at N1197 (P = 0.0037);Gain of methylation at N1197 (P = 0.0037);Gain of methylation at N1197 (P = 0.0037);Gain of methylation at N1197 (P = 0.0037);Gain of methylation at N1197 (P = 0.0037);Gain of methylation at N1197 (P = 0.0037);.;Gain of methylation at N1197 (P = 0.0037);.;.;.;
MVP
0.75
MPC
1.7
ClinPred
0.86
D
GERP RS
-3.7
Varity_R
0.45
gMVP
0.94

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr19-11144010; API